フルテキストURL fulltext.pdf
著者 Ogawa-Akiyama, Ayu| Sugiyama, Hitoshi| Kitagawa, Masashi| Tanaka, Keiko| Kano, Yuzuki| Mise, Koki| Otaka, Nozomu| Tanabe, Katsuyuki| Morinaga, Hiroshi| Kinomura, Masaru| Uchida, Haruhito A.| Wada, Jun|
発行日 2020-01-24
出版物タイトル PLoS ONE
15巻
1号
出版者 Public Library of Science
ISSN 1932-6203
資料タイプ 学術雑誌論文
言語 English
OAI-PMH Set 岡山大学
著作権者 © 2020 Ogawa-Akiyama et al.
論文のバージョン publisher
PubMed ID 31978139
DOI 10.1371/journal.pone.0228337
Web of Science KeyUT 000534599100142
関連URL isVersionOf https://doi.org/10.1371/journal.pone.0228337
JaLCDOI 10.18926/AMO/57710
フルテキストURL 73_6_475.pdf
著者 Umebayashi, Ryoko| Uchida, Haruhito A.| Wada, Junzo|
抄録 Abdominal aortic aneurysms (AAAs) usually expand asymptomatically until the occurrence of a life-threatening event such as aortic rupture, which is closely associated with high mortality. AAA and aortic dissection are ranked among the top 10 causes of death in Japan. The major risk factors for AAA are age over 65 years, male gender, family history, and smoking. Thus, for prevention, smoking cessation is the most important lifestyle-intervention. For treatment, since AAA generally affects elderly people, less invasive treatment is preferable. However, the only established treatment for AAA is open repair and endovascular repair. This review describes potential medical treatments to slow aneurysm growth or prevent AAA rupture.
キーワード abdominal aortic aneurysms medical treatment anti-platelet drugs
Amo Type Review
発行日 2019-12
出版物タイトル Acta Medica Okayama
73巻
6号
出版者 Okayama University Medical School
開始ページ 475
終了ページ 477
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 English
著作権者 CopyrightⒸ 2019 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 31871328
Web of Science KeyUT 000503431400001
JaLCDOI 10.18926/AMO/31860
フルテキストURL fulltext.pdf
著者 Kaihara, Masanobu| Nakamura, Yoshio| Sugimoto, Taro| Uchida, Haruhito A.| Norii, Hisanao| Hanayama, Yoshihisa| Makino, Hirofumi|
抄録 <p>We investigated the impact of olmesartan and temocapril on pancreatic islet beta-cells during the development of diabetes mellitus using Otsuka-Long-Evans-Tokushima Fatty (OLETF) rats. Four-week-old male OLETF rats were fed standard chow (untreated:n5), or chow containing either 0.005% olmesartan(n5) or 0.01% temocapril (n5) until being sacrificed at 35 weeks of age. Pancreas sections were double-stained with anti-insulin and anti-glucagon antibodies. The percent areas of beta-cells, alpha-cells and non-alpha-non-beta-cells were compared among groups. In untreated OLETF rats, the fasting plasma glucose (FPG) level was elevated at the 18th week and remained elevated until the 35th week. On the other hand, no significant elevation in FPG levels was observed in olmesartan- or temocapril-treated rats. Pancreatic islets from olmesartan-treated rats were significantly smaller in size as compared with those from untreated OLETF rats. Furthermore, the average area occupied by beta-cells as a fraction of the total area of an individual islet was significantly higher in olmesartan- or temocapril-treated rats than that in untreated OLETF rats. Olmesartan and temocapril both prevented the development of hyperglycemia, possibly through the prevention of islet beta-cell loss in spontaneously diabetic OLETF rats.</p>
キーワード angiotensin II type-1 receptor blocker angiotensin converting enzyme inhibitor pancreas insulin secretion Type 2 diabetes mellitus
Amo Type Original Article
発行日 2009-02
出版物タイトル Acta Medica Okayama
63巻
1号
出版者 Okayama University Medical School
開始ページ 35
終了ページ 42
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 English
論文のバージョン publisher
査読 有り
PubMed ID 19247421
Web of Science KeyUT 000263730300005